Recursion Pharmaceuticals Past Performance
How has Recursion Pharmaceuticals performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
-67.6%
Last years earnings growth
Earnings and Revenue History
Quality Earnings: RXRX is currently unprofitable.
Growing Profit Margin: RXRX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if RXRX's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare RXRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RXRX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (53%).
Return on Equity
High ROE: RXRX has a negative Return on Equity (-63.63%), as it is currently unprofitable.